Article
A novel molecular classification of diffuse large B cell lymphoma based on Metabolism-related genes
2020-12-23
Abstract excerpt
<title>Abstract</title> <p>Purpose About 30–40% of patients with diffuse large B-cell lymphoma (DLBCL) relapse or fail to respond to first-line treatment. The molecular heterogeneity is considered to be the main factor affecting the therapeutic response of DLBCL. The existing classification methods can not fully explain these heterogeneity, so we try to explain DLBCL heterogeneity by defining DLBCL subtypes from...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ea795170-4c66-5f48-bcbb-ca1618559a7b
- DOI
- 10.21203/rs.3.rs-132445/v1
